Semaglutide GLP-1, Mounjaro, Wegovy, and Ozempic have been shown to be effective in promoting weight loss in adults with obesity, but the long-term effects on weight maintenance are still being studied
Here is a simple breakdown based on the 6-day half-life: After 6 days, 50% of the dose remains After 12 days, 25% remains After 18 days, 12.5% remains After 24 days, about 6% remains After 30 days, less than 4% remains In practice, most pharmacologists consider a drug effectively cleared after 5 half-lives
Depending on your states telehealth regulations, this review will be conducted either through a SYNC (live) or ASYNC (offline) telehealth visit
Muscle Mass and Glucagon-like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss? Circulation, vol